REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fundacion Instituto de Inmunologia de Colombia (Colombia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Fundacion Instituto de Inmunologia de Colombia Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

The company Fundacion Instituto De Inmunologia De Colombia Que Podra Abreviarse En Fidic is primarily engaged in scientific research and development services and related activities. It's been operating in the Colombian market since 2001.

Headquarters
Cr 50 # 26 - 20
Bogota D.C.; Bogota D.C; Postal Code: 0609

Contact Details: Purchase the Fundacion Instituto de Inmunologia de Colombia report to view the information.

Basic Information
Total Employees:
Purchase the Fundacion Instituto de Inmunologia de Colombia report to view the information.
Outstanding Shares:
Purchase the Fundacion Instituto de Inmunologia de Colombia report to view the information.
Incorporation Date:
March 23, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Fundacion Instituto de Inmunologia de Colombia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
3.95%▲
Total operating revenue
3.95%▲
Total assets
6.06%▲
Total equity
-34.77%▼
Quick Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo